UroGen Pharma Ltd. (URGN) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $109.79M | +21.4% |
| 2024 | $90.40M | +9.3% |
| 2023 | $82.71M | +28.5% |
| 2022 | $64.36M | +34.0% |
| 2021 | $48.04M | +307.2% |
| 2020 | $11.80M | +65450.0% |
| 2019 | $18.0K | -98.4% |
| 2018 | $1.13M | -86.2% |
| 2017 | $8.16M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $109.79M | +21.4% |
| 2024 | $90.40M | +9.3% |
| 2023 | $82.71M | +28.5% |
| 2022 | $64.36M | +34.0% |
| 2021 | $48.04M | +307.2% |
| 2020 | $11.80M | +65450.0% |
| 2019 | $18.0K | -98.4% |
| 2018 | $1.13M | -86.2% |
| 2017 | $8.16M | — |